Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
AINO.STthis companyAino Health AB (publ)	SEK 0.18	-5.72×	-5.45×	1.34×	-11.4×	9.1%	-16.4%	-20.0%	-23.4%	95.1%	-278.5%	-6.9%	-1.3×	-0.77×	-6.08×	0.89×	0.0%	3	-0.85	2	C
EPIS-B.STEpisurf Medical AB	SEK 0.06	-0.63×	0.77×	2.71×	-0.74×	-817.4%	-429.6%	-447.4%	-431.1%	-122.5%	-115.3%	-169.4%	0.14×	0.01×	-100.67×	1.7×	0.0%	4	-0.62	2	C
EXPRS2.STExpreS2ion Biotech Holding AB (publ)	SEK 0.91	-1.19×	1.27×	12.37×	0×	1336.2%	-1171.5%	-1444.4%	-1041.4%	-106.7%	-121.9%	-90.4%	0.06×	0.88×	-117.12×	2.04×	0.0%	2	-2.66	3	B
MODTX.STModus Therapeutics Holding AB	SEK 0.17	-1.01×	2.1×	0×	-0.42×	4.5%	0.0%	0.0%	0.0%	-204.4%	-200.3%	-94.9%	0×	0.63×	-45.3×	3.51×	0.0%	1	-38.3	2	C
ODI.STODI Pharma AB	SEK 1.33	21.82×	18.52×	1.34×	15.65×	-2478.3%	31.2%	7.6%	6.0%	83.7%	105.4%	10.4%	0×	-1.31×	4.15×	1.81×	0.0%	6	13.25	3	B-
ORTI-B.STOrtivus AB (publ)	SEK 1.15	-2.9×	2.8×	0.86×	-6.94×	-251.1%	40.3%	-19.7%	-29.8%	-97.6%	-34.4%	-55.5%	0.87×	-1.01×	-7.78×	0.98×	0.0%	1	1.31	1	D+
Peer median	—	-1.01×	2.1×	1.34×	-0.42×	-251.1%	0.0%	-19.7%	-29.8%	-106.7%	-115.3%	-90.4%	0.06×	0.01×	-45.3×	1.81×	0.0%	2	-0.62	2	—